|
|
Volumn 35, Issue 3 SUPPL., 2003, Pages S84-S88
|
|
Sirolimus experience at a Swedish transplantation center
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOSPORIN A;
DILTIAZEM;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
CAUSE OF DEATH;
CEREBROVASCULAR DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
GLOMERULUS FILTRATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART INFARCTION;
HUMAN;
HUMAN TISSUE;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
LUNG TUBERCULOSIS;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PNEUMONIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SINGLE BLIND PROCEDURE;
SOLID PHASE EXTRACTION;
SURVIVAL RATE;
SWEDEN;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
VOLUNTEER;
|
|
EID: 0038637978
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00239-2 Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (11)
|
